Kazia Therapeutics (KZIA) Net Income towards Common Stockholders (2009 - 2024)
Kazia Therapeutics (KZIA) posted Net Income towards Common Stockholders of -$13.27 million for the year ended Jun 30, 2025.
Powered by 
Analysis
Kazia Therapeutics (KZIA) Net Income towards Common Stockholders (2009 - 2024) Analysis & Trends
Since the year ended Dec 31, 2009, Kazia Therapeutics has reported Net Income towards Common Stockholders for 17 years.
- The figure for the year ended Jun 30, 2025 stands as the highest annual Net Income towards Common Stockholders since the year ended Dec 31, 2021.
- Business Quant data shows KZIA's Net Income towards Common Stockholders at -$17.51 million in the year ended Dec 31, 2024, -$13.32 million in the year ended Dec 31, 2023, -$17.39 million in the year ended Dec 31, 2022 and -$6.33 million in the year ended Dec 31, 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.61 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -248.00 Mn |
| 10 | Kazia Therapeutics | 68.33 Mn | 68.33 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | -17.65 Mn |
| Dec 31, 2023 | -13.25 Mn |
| Jun 30, 2017 | -8.02 Mn |
| Dec 31, 2016 | -9.12 Mn |
| Jun 30, 2016 | -9.03 Mn |
| Dec 31, 2015 | -5.26 Mn |
| Dec 31, 2014 | -6.47 Mn |
| Dec 31, 2013 | -3.06 Mn |
| Aug 30, 2013 | -3.86 Mn |
| Dec 31, 2012 | 2.56 Mn |
| Dec 31, 2011 | 1,000.00 |
| Dec 31, 2010 | 1,000.00 |
| Dec 31, 2009 | -23.79 Mn |
API Access
Kazia Therapeutics Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=KZIA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "KZIA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=KZIA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();